Reversal of Vitamin K Antagonist (VKA) effect in patients with severe bleeding: a French multicenter observational study (Optiplex) assessing the use of Prothrombin Complex Concentrate (PCC) in current clinical practice
暂无分享,去创建一个
C. Samama | R. Jaussaud | P. Clerson | J. Crave | T. Desmettre | E. Dehours | Suchin Jhundoo | F. Pujeau | Christian Guillaudin | C. Hecquart | É. Dehours
[1] M. Huguier,et al. La Haute autorité de Santé (HAS) , 2013 .
[2] J. Coquart,et al. Emergency reversal of anticoagulation: the real use of prothrombin complex concentrates: a prospective multicenter two year French study from 2006 to 2008. , 2012, Thrombosis research.
[3] D. Poli,et al. The Practical Management of Intracerebral Hemorrhage Associated with Oral Anticoagulant Therapy , 2011, International journal of stroke : official journal of the International Stroke Society.
[4] R. V. van Hest,et al. Fixed versus variable dose of prothrombin complex concentrate for counteracting vitamin K antagonist therapy , 2011, Transfusion medicine.
[5] W. Ageno,et al. Emergency reversal of anticoagulation with a three-factor prothrombin complex concentrate in patients with intracranial haemorrhage. , 2011, Blood transfusion = Trasfusione del sangue.
[6] M. Makris,et al. Three or four factor prothrombin complex concentrate for emergency anticoagulation reversal? , 2011, Blood transfusion = Trasfusione del sangue.
[7] C. Anderson,et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2010, Stroke.
[8] G. Pernod,et al. French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding). , 2010, Thrombosis research.
[9] J. Suarez,et al. Prothrombin Complex Concentrates for Oral Anticoagulant Therapy-Related Intracranial Hemorrhage: A Review of the Literature , 2010, Neurocritical care.
[10] B. Vigué. Bench-to-bedside review: Optimising emergency reversal of vitamin K antagonists in severe haemorrhage – from theory to practice , 2009, Critical care.
[11] F. Testai,et al. Correction of coagulopathy in warfarin associated cerebral hemorrhage , 2009, Current opinion in critical care.
[12] Mark Crowther,et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.
[13] W. Freeman,et al. Management of warfarin-related intracerebral hemorrhage , 2008, Expert review of neurotherapeutics.
[14] C. Leissinger,et al. Role of prothrombin complex concentrates in reversing warfarin anticoagulation: A review of the literature , 2008, American journal of hematology.
[15] M. Aguilar,et al. Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation , 2007, Annals of Internal Medicine.
[16] Susan Regan,et al. Major Hemorrhage and Tolerability of Warfarin in the First Year of Therapy Among Elderly Patients With Atrial Fibrillation , 2007, Circulation.
[17] Michael D Hill,et al. Determinants of Intracerebral Hemorrhage Growth: An Exploratory Analysis , 2007, Stroke.
[18] D. Benhamou,et al. Ultra-rapid management of oral anticoagulant therapy-related surgical intracranial hemorrhage , 2007, Intensive Care Medicine.
[19] J. Broderick,et al. The increasing incidence of anticoagulant-associated intracerebral hemorrhage , 2007, Neurology.
[20] W. Ageno,et al. Treatment of coumarin‐associated coagulopathy: a systematic review and proposed treatment algorithms , 2006, Journal of thrombosis and haemostasis : JTH.
[21] M. Kaste,et al. Recommendations for the Management of Intracranial Haemorrhage – Part I: Spontaneous Intracerebral Haemorrhage , 2006, Cerebrovascular Diseases.
[22] G. Chang. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage , 2006, Neurology.
[23] S M Davis,et al. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage , 2006, Neurology.
[24] John Spandorfer,et al. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding. , 2006, Archives of internal medicine.
[25] Eric E. Smith,et al. Timing of Fresh Frozen Plasma Administration and Rapid Correction of Coagulopathy in Warfarin-Related Intracerebral Hemorrhage , 2006, Stroke.
[26] T. Steiner,et al. Intracerebral Hemorrhage Associated With Oral Anticoagulant Therapy: Current Practices and Unresolved Questions , 2006, Stroke.
[27] R. Hart,et al. Avoiding Central Nervous System Bleeding During Antithrombotic Therapy: Recent Data and Ideas , 2005, Stroke.
[28] Margaret C Fang,et al. Advanced Age, Anticoagulation Intensity, and Risk for Intracranial Hemorrhage among Patients Taking Warfarin for Atrial Fibrillation , 2004, Annals of Internal Medicine.
[29] J. Hanley. Warfarin reversal , 2004, Journal of Clinical Pathology.
[30] S. Greenberg,et al. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage , 2004, Neurology.
[31] D. Singer,et al. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. , 2004, Archives of internal medicine.
[32] James Douketis,et al. Clinical Impact of Bleeding in Patients Taking Oral Anticoagulant Therapy for Venous Thromboembolism , 2003, Annals of Internal Medicine.
[33] S. Ridley,et al. Drugs in anaesthesia , 2003, Anaesthesia.
[34] H. Naritomi,et al. Effect of prothrombin complex concentrate on INR and blood coagulation system in emergency patients treated with warfarin overdose , 2003, Annals of Hematology.
[35] David A Fitzmaurice,et al. ABC of antithrombotic therapy : Bleeding risks of , 2002 .
[36] B. Norrving,et al. Management and Prognostic Features of Intracerebral Hemorrhage During Anticoagulant Therapy: A Swedish Multicenter Study , 2001, Stroke.
[37] S. Mörsdorf,et al. The use of prothrombin complex concentrates in the treatment of hemorrhages induced by oral anticoagulation. , 1999, Thrombosis research.
[38] M. Köhler. Thrombogenicity of prothrombin complex concentrates. , 1999, Thrombosis research.
[39] R. Beyth,et al. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. , 1998, The American journal of medicine.
[40] F. Rosendaal,et al. Emergency Oral Anticoagulant Reversal: The Relative Efficacy of Infusions of Fresh Frozen Plasma and Clotting Factor Concentrate on Correction of the Coagulopathy , 1997, Thrombosis and Haemostasis.
[41] Vittorio Pengo,et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT) , 1996, The Lancet.
[42] J. Vandenbroucke,et al. Optimal oral anticoagulant therapy in patients with mechanical heart valves. , 1995, The New England journal of medicine.
[43] E. Hylek,et al. Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin , 1994, Annals of Internal Medicine.
[44] Loeliger Ea. [No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery]. , 1993 .
[45] J. Houben,et al. [No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery]. , 1993, Nederlandsch tijdschrift voor geneeskunde.
[46] J. Broderick,et al. Volume of Intracerebral Hemorrhage: A Powerful and Easy‐to‐Use Predictor of 30‐Day Mortality , 1993, Stroke.
[47] B. Norrving,et al. Emergency Reversal of Anticoagulation After Intracerebral Hemorrhage , 1992, Stroke.
[48] G. Harbauer,et al. Comparison of different prothrombin complex concentrates--in vitro and in vivo studies. , 1990, Thrombosis research.
[49] J. V. van Swieten,et al. Intracerebral hematomas during anticoagulant treatment. , 1990, Stroke.
[50] J. Miller,et al. Traumatic acute subdural hematoma: major mortality reduction in comatose patients treated within four hours. , 1981, The New England journal of medicine.
[51] S. Mayer,et al. Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. , 2007, Mayo Clinic proceedings.
[52] P. Strengers,et al. Individualized dosing regimen for prothrombin complex concentrate more effective than standard treatment in the reversal of oral anticoagulant therapy: an open, prospective randomized controlled trial. , 2006, Thrombosis research.
[53] J. Broderick,et al. Location and outcome of anticoagulant-associated intracerebral hemorrhage , 2006, Neurocritical care.
[54] H. Naritomi,et al. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation. , 2005, Thrombosis research.